Li Yu - Jun 24, 2021 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
VP Cntrllr/Prncpl Acctng Offcr
Signature
/s/ Li Yu
Stock symbol
OCX
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
4
Date filed
10/14/2021, 04:05 PM
Previous filing
May 24, 2021
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +160K $0.00 160K Jun 24, 2021 Common Stock 160K $4.33 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option award was granted on May 18, 2021, but such award was subject to shareholder approval of an increase in the number of shares available for issuance under the Oncocyte 2018 Equity Incentive Plan. Such shareholder approval was received on June 24, 2021.
F2 25% of the options will become exercisable after one year of continuous employment from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to continued employment on the applicable vesting date.